Nektar Therapeutics (NKTR) PT Raised to $115 at Oppenheimer
Tweet Send to a Friend
(Updated - December 16, 2025 11:04 AM EST)
Oppenheimer analyst Jay Olson raised the price target on Nektar Therapeutics ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
Oppenheimer analyst Jay Olson raised the price target on Nektar Therapeutics ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
